Veracyte, Inc.
NASDAQ: VCYT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Marc A. Stapley
- Employees
- 824
- Headquarters
- South San Francisco, United States
- IPO year
- 2013
- Market cap
- $4.3B
- Website
- https://www.veracyte.com
Loading VCYT…
Loading profile data…Frequently asked questions about VCYT
What does Veracyte, Inc. (VCYT) do?
Veracyte, Inc. operates as a global diagnostics company, specializing in the development and commercialization of advanced genomic tests. The company's product portfolio encompasses several key diagnostic solutions: The Afirma Genomic Sequencing Classifier and Xpression Atlas, which help patients with indeterminate thyroid nodule results avoid u...
Where does VCYT trade?
Veracyte, Inc. (VCYT) trades on the NASDAQ Global Market.
What sector is VCYT in?
Veracyte, Inc. (VCYT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Veracyte, Inc.?
Marc A. Stapley is the chief executive officer of Veracyte, Inc. (VCYT).
Where is Veracyte, Inc. headquartered?
Veracyte, Inc. is headquartered in United States.
Does VCYT pay a dividend?
Veracyte, Inc. (VCYT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VCYT go public?
Veracyte, Inc. (VCYT) completed its initial public offering in 2013.